MedTrace Logo

Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure

NCT00180648 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-02-22

No results posted yet for this study

Summary

The purpose of this study is to investigate the theory that the plasma level of Glucagon like peptide 2 (GLP-2) in patients with intestinal failure can predict their clinical recovery.

Conditions

  • Short Bowel Syndrome

Sponsors & Collaborators

  • Centre for Ocular Research & Education, Canada

    collaborator OTHER

  • St Mark's Hospital Foundation

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Alastair Forbes · University College London Hospitals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2008-02-29
Completion
2008-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00180648 on ClinicalTrials.gov